Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BRENNAN, M. J.
Right arrow Articles by REBUCK, J. W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by BRENNAN, M. J.
Right arrow Articles by REBUCK, J. W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 1960, Vol. 16, No. 5, pp. 1535-1545.
© 1960 American Society of Hematology, Inc.


Megaloblastic Anemia Associated with Inhibition of Thyrmine Synthesis (Observations During 5-fluorouracil Treatment)

M. J. BRENNAN , V. K. VAITKEVICIUS , and J. W. REBUCK

Megaloblastic changes in the erythrocytic series and cellular giantism in the myeloid line characterize the bone marrow response to 5-fluorouracil in man.

Cytoplasmic vacuolizations occur in reticulo-endothelial cells, megakaryocytes, and myeloid elements.

During development of these morpholigic changes in marrow, associated cellular giantism, polynucleism, and nuclear pattern changes appear in the oral, vaginal, colonic mucosa, and in some tumors resembling those encountered in the bone marrow.

The myeloid-erythroid ratio was found to be useful for the purpose of identifying dosage end-points.

The physiological implications Of these changes as related to nucleic acid metabolism were discussed.

Submitted on January 7, 1960
Accepted on January 13, 1960


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1960 by American Society of Hematology         Online ISSN: 1528-0020